Cognitive Behavioral Therapy for Suicide Prevention in Psychosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a special therapy called CBSPp to help adults with schizophrenia who have had recent suicidal thoughts. The therapy aims to change harmful thoughts and behaviors to reduce the risk of suicide.
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 18-65 with a schizophrenia spectrum disorder who have had suicidal thoughts or behaviors in the last 3 months. It's not suitable for those needing emergency care, with impaired cognitive capacity, or deemed inappropriate for behavioral treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) in 10 weekly individual therapy sessions
Assessment
Quantitative assessments at baseline, 1-month, 3-months, and 5-months after baseline with in-depth qualitative interviews at 3-months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Suicide Prevention for psychosis (CBSPp)
- Services as Usual (SAU)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator